Concepedia

Audrey Gill

AG

Statistics

Publications

6

Citations

423

H-Index

6

Active since

2020

Affiliations

Cornell University(Current)

Memorial Sloan Kettering Cancer Center

Epic Sciences (United States)

Denali Therapeutics (United States)

Audrey Gill is an author at Cornell University specializing in medicine, castration-resistant prostate cancer therapy, and tumor progression.

Publications per year

2020–2023

6

Publications

6

A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models

Bettina van Lengerich, Lihong Zhan, Dan Xia et al. · Nature Neuroscience · 2023 · 222 citations · Full text

, , +17

CD98hc is a target for brain delivery of biotherapeutics

Kylie S. Chew, Robert C. Wells, Arash Moshkforoush et al. · Nature Communications · 2023 · 88 citations · Full text

, , +17

Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer

Joseph D. Schonhoft, Jimmy L. Zhao, Adam Jendrisak et al. · Cancer Research · 2020 · 42 citations · Full text

, , +17

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

Landon C. Brown, Susan Halabi, Joseph D. Schonhoft et al. · Clinical Cancer Research · 2021 · 37 citations · Full text

, , +17

Uncovering the cellular capacity for intensive and specific feedback self-control of the argonautes and MicroRNA targeting activity

Degeng Wang, Tingzeng Wang, Audrey Gill et al. · Nucleic Acids Research · 2020 · 17 citations · Full text

, , +15

1–5 of 6